BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 05 2024
0mins
Source: Globenewswire
Corporate Update Announcement: BioCardia, Inc. will provide a corporate update and financial results for Q3 2024 on November 13, 2024, via conference call, followed by a Q&A session.
Company Overview: BioCardia specializes in cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, with ongoing development of its CardiAMP and CardiALLO cell therapy platforms.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
